Michael Gleeson MD-PhD ’10, once disabled by reactive arthritis, regained his health with the right medical care and the help of his wife, Kirsten. His experience inspired him to become a physician-researcher.
With funding from the Falk Foundation, Mike Whitfield’s lab is mapping which genes interact with each other in the debilitating disease scleroderma. Their discoveries reveal new avenues for treatment.
The shells of a common plant virus, inhaled into a lung tumor or injected into ovarian, colon or breast tumors, not only triggered the immune system in mice to wipe out the tumors, but provided systemic protection against metastases, report researchers from Dartmouth and Case Western Reserve University.
Geisel MD-PhD candidate Yike Jiang received the Priscilla Schaffer Award for Outstanding Graduate Student Presentation during the 40th annual International Herpesvirus Workshop, which brings together more than 600 investigators from around the world.
The Guardian – This article mentions Dartmouth’s Geisel School of Medicine in an article about the overall impact of a cancer immunotherapy clinical trial on melanoma patients, and that the two drugs used in the trial, ipilimumab and nivolumab, were created by the biotech firm called Medarex founded by immunologists from Geisel.
Dartmouth researchers are among 37 principal investigators and their dedicated trainees to receive the American Association of Immunologists inaugural Careers in Immunology Fellowship award.
An article published in the journal Science provides support for a new—and still controversial—understanding of the immune system.
Dartmouth researchers are exploring ways to use nano particles to wake up the immune system so it recognizes and attacks invading cancer cells.
From the litter box to the laboratory, a microscopic organism native to cats shows promise in treating cancer. Dartmouth researchers’ mutated strain of T. gondii reprograms the natural power of the immune system to kill cells.